Seriously ASIC need to look at this!, page-82

First 82 Last

Share
Profile

Follow
Toxxxic

2,796 Posts.

08/12/15

10:28

Post #: 16566954
Share

Originally posted by nine lives ↑

It always has to be one thing or the other on HC doesn't it.....either a stock is the next facebook or it is a fraud and there is nothing in between. When things were going really well for 1PG I made the comment several times that I believe this is a good company that got waaaaaaaay ahead of itself on pure market excitement. I also pointed out the gap in the chart around 2 bucks and also put some perspective on that by saying that even if the gap is filled 1PG will still be a ten bagger from the raise price. There is nothing disgraceful about that. On top of that they managed to get a massive cap raise away while the price was sky high so in the medium term there should be no further dilution. That raise was a very smart move by the company.

If anyone disagrees with my outlook I would suggest you give consideration to XRO. They have become the standard for accounting in the cloud. When they had their own exuberant momentum rise they got to about 43 bucks a share in march 2014. they hit a low this year in that market slump we had around aug/sept of about 12 bucks!!!! They are now sitting the 16 - 17 buck range. This drop does not mean they are a flop or a fraud. XRO are not going away. It just means that the euphoria faded and reality set in. XRO will probably now slowly grind its way upwards and eventually revisit the old highs and perhaps exceed them. I would suggest that it is quite possible that they are following a well worn trail that 1PG will also eventually follow.

Expand

Couldn't agree more NL. The markets move on fear and greed - human emotions. 1PG reminds me a LOT of XRO, a company I've been following for a long time (I'm a kiwi). I think the $2 level represents reasonably value, both technically and fundamentally.

I'm sure a lot of people are thinking the same, based purely off the chart, so I'm sure there will at least be some kind of short term bounce at the very least from those levels.

1PG should go on to back up the hype, but no doubt it got way ahead of itself, and unfortunately for those who bought at the top, it's just the way the market works.

1PG Price at posting: $2.52 Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 82 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Seriously ASIC need to look at this!, page-82

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News